MARKET

SRDX

SRDX

Surmodics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

52.65
-1.51
-2.79%
Opening 13:24 05/11 EDT
OPEN
53.29
PREV CLOSE
54.16
HIGH
54.31
LOW
52.65
VOLUME
17.39K
TURNOVER
--
52 WEEK HIGH
59.75
52 WEEK LOW
33.45
MARKET CAP
730.15M
P/E (TTM)
101.60
1D
5D
1M
3M
1Y
5Y
How to trade Surmodics #SRDX With Risk Controls
May 09, 2021 (Stock Traders Daily via COMTEX) -- Price matters most to #makingmoney in the #stockmarket. Celebrating 20 years, Stock Traders Daily provides...
Stock Traders Daily · 2d ago
Shares of SRDX Up 41.8% Since Uptrend Call on Shares
May 05, 2021 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Surmodics Inc (NASDAQ:SRDX) on December 4th, 2020 at $39.78. In...
marketwatch.com · 5d ago
Antimicrobial Coatings Market Projected to Reach Around USD 9.52 Billion by 2027
May 05, 2021 (Market Stats News via COMTEX) -- The global antimicrobial coatings market size is projected to reach around USD 9.52 billion by 2027. Growing...
Market Stats News · 6d ago
Medical Grade Coatings Market Global Industry Growth Analysis, Opportunities, Trends and Forecast 2021-2031
May 03, 2021 (MARKITWIRED via COMTEX) -- Recently a market study published by Future Market Insights (FMI) on the Medical Grade Coatings market includes the...
Markitwired · 05/03 04:19
Surmodics (SRDX) Q2 Earnings Beat Estimates, Revenues Miss
Surmodics (SRDX) records higher revenues in both its core units in the fiscal second quarter.
Zacks · 04/29 17:31
The Fundamental Case for Surmodics #SRDX Using a Price Based Model
Apr 29, 2021 (Stock Traders Daily via COMTEX) -- Traditionally #WallStreet has used #fundamentalanalysis to make #investmentdecisions in #stocks like...
Stock Traders Daily · 04/29 11:08
DJ Surmodics, Inc.'s CEO Gary Maharaj on Q2 2021 Results -- Earnings Call Transcript >SRDX
Dow Jones · 04/28 22:00
10-Q: SURMODICS INC
(EDGAR Online via COMTEX) -- Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations The following discussion and...
Edgar Online - (EDG = 10Q, 10K) · 04/28 19:50
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SRDX. Analyze the recent business situations of Surmodics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SRDX stock price target is 74.25 with a high estimate of 83.00 and a low estimate of 68.00.
EPS
Institutional Holdings
Institutions: 203
Institutional Holdings: 12.60M
% Owned: 90.88%
Shares Outstanding: 13.87M
TypeInstitutionsShares
Increased
42
246.90K
New
12
124.42K
Decreased
53
287.18K
Sold Out
13
59.12K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.54%
Healthcare Equipment & Supplies
-0.42%
Key Executives
Non-Executive Chairman/Independent Director
Susan Knight
Chief Executive Officer/President/Director
Gary Maharaj
Chief Financial Officer/Senior Vice President - Finance
Timothy Arens
Senior Vice President/Chief Marketing Officer
Teri Sides
Senior Vice President/General Counsel/Secretary
Gordon Weber
Senior Vice President/General Manager
Joseph Stich
Senior Vice President
Charles Olson
Vice President
Nusrath Sultana
Independent Director
Jose Bedoya
Independent Director
David Dantzker
Independent Director
Lisa Heine
Independent Director
Ronald Kalich
No Data
About SRDX
Surmodics, Inc. is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company's Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices; international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device. The Company's In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. The In Vitro Diagnostics segment manufactures and sells surface coatings to the diagnostic, biomedical research and life science markets. In Vitro Diagnostics segment offers protein stabilization reagents, substrates, antigens and surface coatings.

Webull offers kinds of SurModics, Inc. stock information, including NASDAQ:SRDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRDX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SRDX stock methods without spending real money on the virtual paper trading platform.